trending Market Intelligence /marketintelligence/en/news-insights/trending/Qs5b6aT5G-RWdXf-vCGHfQ2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Aevi Genomic attracts $28M investment

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Aevi Genomic attracts $28M investment

Aevi Genomic Medicine Inc. will sell $28 million in shares to a number of investors, including the Children's Hospital of Philadelphia Foundation, which is leading the offering.

The company will issue 22,222,222 shares at $1.26 apiece, complete with warrants to purchase up to an additional 3,953,904 stocks.

The Children's Hospital of Philadelphia has also committed up to a further $5 million in equity financing until June 30, 2018.

Aevi Genomic will use the net proceeds for the development of its two lead clinical programs along with other product candidates, support its collaboration with Children's Hospital of Philadelphia and for general corporate purposes.

Closing is expected to occur in the fourth quarter.

Jefferies LLC is advising Aevi Genomic on the transaction, with Evercore LLC advising the Children's Hospital of Philadelphia.